GlassScriptPhysician profile
Laarnie Chaco
NPI 1568760551
$3,894.86
in general payments reported to CMS, 2019-2025
28 companies · $20.44 in 2025
The $20.44 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,006 · 2022: $1,298 · 2023: $885 · 2024: $686 · 2025: $20.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,591.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $896.93 | 2021-2024 | |
| Collegium Pharmaceutical, INC. | $435.56 | 2021-2024 | Belbuca, Xtampza, Nucynta |
| Grt US Holding, INC. | $399.72 | 2022 | |
| Abbott Laboratories | $392.84 | 2021-2025 | Proclaim, Eterna, Freestyle Libre |
| Biohaven Pharmaceutical Holding Company LTD. | $282.66 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $243.32 | 2021 | |
| Pfizer INC. | $194.28 | 2021-2024 | |
| Lilly USA, LLC | $134.03 | 2021-2023 | Reyvow, Emgality |
| Bioventus LLC | $99.32 | 2022-2023 | Durolane, Gelsyn-3 |
| Averitas Pharma INC. | $85.31 | 2023-2024 | Qutenza |
| Amgen INC. | $81.69 | 2021 | |
| Eisai INC. | $72.53 | 2021 | |
| Nevro Corp. | $64.44 | 2021-2024 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.56 | 2021-2022 | |
| Ipsen Biopharmaceuticals, INC | $52.96 | 2024 | Dysport |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $49.97 | 2021-2022 | |
| Vertos Medical, INC. | $49.68 | 2024 | Mild Device Kit |
| Nalu Medical, INC. | $46.95 | 2023 | Nalu Neurostimulation System |
| Novartis Pharmaceuticals Corporation | $43.71 | 2021 | |
| Boston Scientific Corporation | $38.81 | 2021-2024 | |
| Saluda Medical Americas, INC. | $33.82 | 2023-2024 | Evoke Scs, Evoke |
| Si-Bone, INC. | $30.92 | 2021-2022 | |
| Azurity Pharmaceuticals, INC. | $24.81 | 2024 | Horizant |
| Stimwave Technologies Incorporated | $22.72 | 2021-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.33 | 2021 | |
| Avanos Medical | $13.95 | 2021 | |
| Biodelivery Sciences International, INC. | $13.64 | 2021 | |
| Medtronic, INC. | $13.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laarnie Chaco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.